Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares, rose in value on Friday, July 11, with the stock price down by -3.52% to the previous day’s close as strong demand from buyers drove the stock to $40.87.
Actively observing the price movement in the last trading, the stock closed the session at $42.36, falling within a range of $38.87 and $42.195. The value of beta (5-year monthly) was 2.105. Referring to stock’s 52-week performance, its high was $130.00, and the low was $6.76. On the whole, TNXP has fluctuated by 8.29% over the past month.
With the market capitalization of Tonix Pharmaceuticals Holding Corp currently standing at about $300.69 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-12.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that TNXP’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of TNXP currently trading nearly 14.40% and 28.82% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 62.14, while the 7-day volatility ratio is showing 8.48% which for the 30-day chart, stands at 8.67%. Furthermore, Tonix Pharmaceuticals Holding Corp (TNXP)’s beta value is 1.71.
A comparison of Tonix Pharmaceuticals Holding Corp (TNXP) with its peers suggests the former has fared considerably weaker in the market. TNXP showed an intraday change of -3.52% in last session, and over the past year, it grew by 23.92%%.
Data on historical trading for Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) indicates that the trading volumes over the past 10 days have averaged 0.81 and over the past 3 months, they’ve averaged 888.98K. According to company’s latest data on outstanding shares, there are 7.36 million shares outstanding.
Nearly 0.07% of Tonix Pharmaceuticals Holding Corp’s shares belong to company insiders and institutional investors own 6.77% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1.13 million shares as on 2025-06-13, resulting in a short ratio of 0.85. According to the data, the short interest in Tonix Pharmaceuticals Holding Corp (TNXP) stood at 1536.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 0.91 million. The stock has fallen by -32.13% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the TNXP stock heading into the next quarter.
